MedPath

Pralidoxime

Generic Name
Pralidoxime
Brand Names
Atnaa, Duodote, Protopam
Drug Type
Small Molecule
Chemical Formula
C7H9N2O
CAS Number
6735-59-7
Unique Ingredient Identifier
P7MU9UTP52

Overview

Pralidoxime is an antidote to organophosphate pesticides and chemicals. Organophosphates bind to the esteratic site of acetylcholinesterase, which results initially in reversible inactivation of the enzyme. If given within 24 hours,after organophosphate exposure, pralidoxime reactivates the enzyme cholinesterase by cleaving the phosphate-ester bond formed between the organophosphate and acetylcholinesterase.

Background

Pralidoxime is an antidote to organophosphate pesticides and chemicals. Organophosphates bind to the esteratic site of acetylcholinesterase, which results initially in reversible inactivation of the enzyme. If given within 24 hours,after organophosphate exposure, pralidoxime reactivates the enzyme cholinesterase by cleaving the phosphate-ester bond formed between the organophosphate and acetylcholinesterase.

Indication

For the treatment of poisoning due to those pesticides and chemicals of the organophosphate class which have anticholinesterase activity and in the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis.

Associated Conditions

  • Toxic effect of organophosphate and carbamate
  • Anticholinesterase overdose

Clinical Trials

FDA Approved Products

Protopam Chloride
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS
Strength:1 g in 20 mL
Approved: 2018/01/01
NDC:60977-141

Singapore Approved Products

PAM-A INJECTION 500 mg/ampoule
Manufacturer:ILDONG PHARMACEUTICAL CO., LTD
Form:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Strength:500 mg/ampoule
Online:Yes
Approved: 1991/02/18
Approval:SIN05412P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath